Orchestra BioMed CFO Receives 181K RSUs—Signal of Confidence Amid $21M Vivasure Deal
Orchestra BioMed CFO’s new 181k‑unit RSU grant shows board confidence, aligns long‑term interests, and signals potential upside after the Vivasure acquisition.
4 minutes to read